These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23452353)

  • 21. Innovation, productivity and the art of risk management.
    Lowe JA; Duckworth M; Jones P
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):549-50. PubMed ID: 17002214
    [No Abstract]   [Full Text] [Related]  

  • 22. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 23. NIH drops reasonable pricing clause.
    Gavaghan H
    Nature; 1995 Apr; 374(6524):669. PubMed ID: 7715715
    [No Abstract]   [Full Text] [Related]  

  • 24. Opening up the Ivory Tower.
    Wilan KH
    Cell; 2007 Jun; 129(5):847-50. PubMed ID: 17540161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. US health bill promises changes for biomedical researchers.
    Wadman M
    Nature; 2010 Mar; 464(7288):479. PubMed ID: 20336105
    [No Abstract]   [Full Text] [Related]  

  • 26. "NIH-money-for-drug-patent-life" proposal rejected.
    Fox JL
    Nat Biotechnol; 1997 Dec; 15(13):1338. PubMed ID: 9415880
    [No Abstract]   [Full Text] [Related]  

  • 27. Ethics. Senate probe of research psychiatrists.
    Kaiser J
    Science; 2009 Jul; 325(5936):30. PubMed ID: 19574367
    [No Abstract]   [Full Text] [Related]  

  • 28. NIH encourages translational collaboration with industry.
    Wadman M
    Nat Rev Drug Discov; 2010 Apr; 9(4):255-6. PubMed ID: 20224566
    [No Abstract]   [Full Text] [Related]  

  • 29. Advisors may urge NIH to seek out industry support for clinical trials.
    Appel A
    Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
    [No Abstract]   [Full Text] [Related]  

  • 30. DOE to industry: so long, partner.
    Lawler A
    Science; 1996 Oct; 274(5284):24-6. PubMed ID: 8848717
    [No Abstract]   [Full Text] [Related]  

  • 31. Collaborative effort.
    Novak K
    Nat Rev Cancer; 2002 Sep; 2(9):638. PubMed ID: 12240637
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 33. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?
    Alifrangis C; Krell J; Stebbing J
    Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231
    [No Abstract]   [Full Text] [Related]  

  • 34. Charity launches not-for-profit drug industry.
    Butler D
    Nature; 2002 Apr; 416(6880):465. PubMed ID: 11932709
    [No Abstract]   [Full Text] [Related]  

  • 35. Institutes in pharma cash probe.
    Ledford H
    Nature; 2008 Jun; 453(7198):963. PubMed ID: 18563109
    [No Abstract]   [Full Text] [Related]  

  • 36. Needed: a center to study medical practice.
    Waxman HA
    Resume; 1977; ():5-6. PubMed ID: 10307798
    [No Abstract]   [Full Text] [Related]  

  • 37. FR-901228 Fujisawa/National Cancer Institute.
    Vigushin DM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1396-402. PubMed ID: 12498018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of academic health centers in improving health.
    Roper WL; Newton WP
    Ann Fam Med; 2006; 4 Suppl 1(Suppl 1):S55-7; discussion S58-60. PubMed ID: 17003165
    [No Abstract]   [Full Text] [Related]  

  • 39. AIDS drug price hike prompts calls for intervention.
    Check E
    Nature; 2004 May; 429(6987):6. PubMed ID: 15129244
    [No Abstract]   [Full Text] [Related]  

  • 40. Terms of Scripps-Sandoz agreement may be more common than its critics believe.
    Mervis J
    Nature; 1993 Mar; 362(6417):194-5. PubMed ID: 8459840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.